We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
GenDx Obtains World Wide Distribution Rights of QIAGEN® LongRange PCR Kit
News

GenDx Obtains World Wide Distribution Rights of QIAGEN® LongRange PCR Kit

GenDx Obtains World Wide Distribution Rights of QIAGEN® LongRange PCR Kit
News

GenDx Obtains World Wide Distribution Rights of QIAGEN® LongRange PCR Kit

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "GenDx Obtains World Wide Distribution Rights of QIAGEN® LongRange PCR Kit"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

On April 26th, QIAGEN has granted GenDx the non-exclusive rights to distribute world-wide, both direct and via third parties, the QIAGEN LongRange PCR kit in combination with the SBTexcellerator® reagents for high resolution HLA typing.

This elevates the cooperation between QIAGEN and GenDx and shows the commitment of both companies to facilitate the tissue typing community world wide with the highest quality products.

The QIAGEN LongRange PCR kit in combination with the GenDx SBTexcellerator® reagents enables amplification of the HLA genes beyond the classic exon 2, 3 and 4 regions.

Thereby, other important regions of the HLA genes can also be identified by sequencing. This provides tissue typers the ultimate tools to achieve the highest resolution of HLA typing and minimize the number of ambiguities.

Wietse Mulder, Managing Director of GenDx commented: “This distribution agreement enables GenDx and her partners to even better fulfil the requirements of our customers worldwide to efficiently obtain reliable HLA-typing results.”

Advertisement